High flow nasal cannula oxygen (hfnc) versus non-invasive positive pressure ventilation (nippv) in acute hypoxemic respiratory failure. a pilot randomized controlled trial
| Autor: | WS Montenegro, JS Prazeres, AL Leitao, J.R.A.D. Azevedo, MM Silva, JP Maranhao |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
business.industry
medicine.medical_treatment chemistry.chemical_element Respiratory Dead Space respiratory system Critical Care and Intensive Care Medicine medicine.disease_cause Oxygen law.invention Airway resistance chemistry Randomized controlled trial law Anesthesia Oxygen therapy Poster Presentation Positive airway pressure medicine Positive pressure ventilation business Nasal cannula |
| Zdroj: | Intensive Care Medicine Experimental |
| ISSN: | 2197-425X |
| DOI: | 10.1186/2197-425x-3-s1-a166 |
| Popis: | Oxygen therapy is generally provided via nasal cannula, non-rebreathing masks and masks with reservoir bags. These devices have various limitations. Despite showing clear benefits in certain conditions, non-invasive positive pressure ventilation (NIPPV) limits mobilization, restricts communication and oral nutrition and is poorly tolerated by some patients due to discomfort. High-flow nasal cannula oxygen (HFNC) delivers a high flow of heated and humidified oxygen through nasal prongs. It generate positive airway pressure, reduces respiratory dead space, airway resistance, and less frequent interruption of therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink